Journal of Clinical Endocrinology & Metabolism, Vol 78, 724-730, Copyright © 1994 by Endocrine Society

ARTICLES

A comparison of lateral versus anterior-posterior spine dual energy x- ray absorptiometry for the diagnosis of osteopenia

JS Finkelstein, RL Cleary, JP Butler, R Antonelli, BH Mitlak, DJ Deraska, JC Zamora-Quezada and RM Neer
Department of Medicine, Massachusetts General Hospital, Boston 02114.

Because bone mineral density (BMD) measurements at various sites differ in the relative amounts of cortical and trabecular bone that they assess, they also differ in their sensitivity for detecting osteopenia. Lateral spine dual energy x-ray absorptiometry (DXA) allows measurement of BMD of the vertebral bodies, which contain mainly trabecular bone, without contribution from the posterior vertebral elements, which are rich in cortical bone. Thus, we hypothesized that lateral spine DXA would detect osteopenia more frequently than anterior-posterior (AP) spine DXA. To assess the ability of DXA to estimate trabecular bone mass, we compared AP and lateral DXA spine measurements with trabecular bone measurements by quantitative computed tomography (QCT) in 58 patients. We then compared AP vs. lateral spine DXA measurements in 1) 300 women referred for routine bone densitometry, 2) 30 glucocorticoid- treated women, and 3) 44 women with vertebral compression fractures. To compare short term reproducibility, we performed repeat AP and lateral DXA scans in 50 women. The association between QCT and DXA measurements was stronger when DXA measurements were made in the lateral (r = 0.784) or midlateral (r = 0.823) projection than in the AP (r = 0.571) projection. The association of BMD with age was stronger when DXA measurements were made in the lateral (r = 0.536) or midlateral (r = 0.536) projection than in the AP (r = 0.382) projection. The declines in BMD with age for AP, lateral, and midlateral DXA measurements were 0.48%, 0.60%, and 0.88%/yr, respectively. In the women referred for routine densitometry, lateral DXA measurements were significantly (P < 0.05) more abnormal than AP measurements compared with those in young women. This was also true in the women treated with glucocorticoids and women with vertebral compression fractures. Lateral DXA often detected osteopenia in patients whose AP DXA was normal. The 95% confidence limits for changes in BMD attributable to measurement error for AP, lateral, and midlateral DXA were 0.027, 0.038, and 0.057 g/cm2, respectively. These results indicate that lateral DXA measurements identify patients with osteopenia more often than AP DXA measurements, probably because lateral DXA more accurately estimates trabecular bone mass. Short term reproducibility of lateral DXA is nearly as good as that for AP DXA.

This article has been cited by other articles:

				S. E. Dolan, J. R. Kanter, and S. Grinspoon Longitudinal Analysis of Bone Density in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2938 - 2945. [Abstract] [Full Text] [PDF]

				K. K. Miller, S. K. Grinspoon, J. Ciampa, J. Hier, D. Herzog, and A. Klibanski Medical Findings in Outpatients With Anorexia Nervosa Arch Intern Med, March 14, 2005; 165(5): 561 - 566. [Abstract] [Full Text] [PDF]

				K. K. Miller, S. Grinspoon, S. Gleysteen, K. A. Grieco, J. Ciampa, J. Breu, D. B. Herzog, and A. Klibanski Preservation of Neuroendocrine Control of Reproductive Function Despite Severe Undernutrition J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4434 - 4438. [Abstract] [Full Text] [PDF]

				X-P Wu, E-Y Liao, R-C Dai, X-H Luo, and H Zhang Effects of projective bone area size of the spine on bone density and the diagnosis of osteoporosis in healthy pre-menopausal women in China Br. J. Radiol., July 1, 2003; 76(907): 452 - 458. [Abstract] [Full Text] [PDF]

				K. K. Miller, B. M. K. Biller, J. Hier, E. Arena, and A. Klibanski Androgens and Bone Density in Women with Hypopituitarism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2770 - 2776. [Abstract] [Full Text] [PDF]

				J. S. Huang, S. J. Wilkie, M. P. Sullivan, and S. Grinspoon Reduced Bone Density in Androgen-Deficient Women with Acquired Immune Deficiency Syndrome Wasting J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3533 - 3539. [Abstract] [Full Text] [PDF]

				S. Grinspoon, E. Thomas, S. Pitts, E. Gross, D. Mickley, K. Miller, D. Herzog, and A. Klibanski Prevalence and Predictive Factors for Regional Osteopenia in Women with Anorexia Nervosa Ann Intern Med, November 21, 2000; 133(10): 790 - 794. [Abstract] [Full Text] [PDF]

				The Effects of Anorexia Nervosa on Bone Metabolism in Female Adolescents J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4489 - 4496. [Abstract] [Full Text]

				S. Grinspoon, K. Miller, C. Coyle, J. Krempin, C. Armstrong, S. Pitts, D. Herzog, and A. Klibanski Severity of Osteopenia in Estrogen-Deficient Women with Anorexia Nervosa and Hypothalamic Amenorrhea J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2049 - 2055. [Abstract] [Full Text]

				J. S. Finkelstein and A. L. Arnold Increases in Bone Mineral Density after Discontinuation of Daily Human Parathyroid Hormone and Gonadotropin-Releasing Hormone Analog Administration in Women with Endometriosis J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1214 - 1219. [Abstract] [Full Text]

				J. S. Finkelstein, A. Klibanski, A. L. Arnold, T. L. Toth, M. D. Hornstein, and R. M. Neer Prevention of Estrogen Deficiency-Related Bone Loss With Human Parathyroid Hormone-(1-34): A Randomized Controlled Trial JAMA, September 23, 1998; 280(12): 1067 - 1073. [Abstract] [Full Text] [PDF]

				J. S. Finkelstein, A. Klibanski, E. H. Schaefer, M. D. Hornstein, I. Schiff, and R. M. Neer Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency N. Engl. J. Med., December 15, 1994; 331(24): 1618 - 1623. [Abstract] [Full Text]